PIK3CA and neoplasm: Evolution of tumor volume prior and after calibration was compared to the experimental data used for calibration for each of the four scenarios: EGFR mutation with or without gefitinib, EGFR and PIK3CA mutation with or without gefitinib (see Fig. 6).